Woori BMO Group Comments on Finance of America Set for IPO Woori BMO Group Oct 16, 2020 06:00 JST Read More
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System Olympus Oct 12, 2020 02:00 HKT/SGT Read More
Moms on Watch: Ni-Q Summary Judgement Illustrates Prolacta's Deceptive Business Practices Moms on Watch Oct 09, 2020 08:00 JST Read More
Eisai: Joint Development Agreement Aiming for Drug Discovery for COVID-19 Utilizing Eritoran and E6011 Concluded Eisai Oct 06, 2020 11:07 HKT/SGT Read More
Eisai: Jyseleca (Filgotinib) Approved in Japan for Rheumatoid Arthritis Eisai Sep 28, 2020 08:04 HKT/SGT Read More
AIM ImmunoTech、オランダ・ロッテルダムのエラスムス大学医療センターより膵臓癌で統計的に有意な陽性の生存率を得る AIM ImmunoTech Inc Sep 23, 2020 07:00 JST Read More
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets (Safinamide Mesilate) in Japan from Meiji Seika Pharma Eisai Sep 07, 2020 08:02 HKT/SGT Read More
Hydromer's Plant Based Sanitizers Show Significant Reduction of COVID-19 Virus and Many Other Microbes Hydromer, Inc. Sep 03, 2020 09:00 JST Read More
Moms on Watch Condemns Lack of Diversity at Prolacta; Demands Prolacta's Leadership Team Reflect the Communities it Serves Moms on Watch Sep 02, 2020 16:00 JST Read More
AIM ImmunoTech、新たなin vitroモデルを用いてSARS-CoV-2感染性ウイルス収量を90%低下、COVID-19の経鼻予防薬としてAmpligenのさらなる試験をサポート AIM ImmunoTech Inc Aug 31, 2020 08:00 JST Read More
Eisai to Launch Sahne Medical Spray and Sahne Medical Cream Eisai Aug 25, 2020 11:55 HKT/SGT Read More
AIM ImmunoTech、2020年第2四半期のビジネスアップデートを発表、COVID-19およびがん試験の進捗状況を報告 AIM ImmunoTech Inc Aug 17, 2020 19:55 JST Read More
Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa's Second COVID-19 Therapeutic Development Program Avance Clinical Jul 22, 2020 14:00 JST Read More
Agilex Biolabs and Endpoints News Present 'How to Move Trials to Australia' Webinar Agilex Biolabs Jul 22, 2020 13:08 JST Read More
AIM ImmunoTech、ロズウェルパーク癌研究所と臨床試験契約を締結、COVID-19がん患者を対象とするAmpligenとインターフェロンアルファ-2bとの併用療法に関する第I/II相臨床試験を支援 AIM ImmunoTech Inc Jul 10, 2020 08:00 JST Read More
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer's Disease Eisai Jul 09, 2020 11:20 HKT/SGT Read More
Eisai and Merck Receive Complete Response Letter for LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma Eisai Jul 09, 2020 11:11 HKT/SGT Read More
Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award Avance Clinical Jul 09, 2020 01:30 JST Read More
Eisai: New Drug Application for In-House Developed New Anti-insomnia Drug Dayvigo Accepted in Hong Kong Eisai Jul 08, 2020 13:33 HKT/SGT Read More
Eisai Submits Marketing Authorization Application in Japan for Anticancer Agent Tazemetostat for EZH2 Gene Mutation-Positive Follicular Lymphoma Eisai Jul 08, 2020 13:16 HKT/SGT Read More
